Logo image of WBEV

WINC INC (WBEV) Stock Fundamental Analysis

NYSEARCA:WBEV - NYSE Arca - US97265W1053 - Common Stock - Currency: USD

0.14  -0.03 (-20%)

After market: 0.14 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to WBEV. WBEV was compared to 30 industry peers in the Beverages industry. WBEV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, WBEV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

WBEV had negative earnings in the past year.
In the past year WBEV has reported a negative cash flow from operations.
WBEV Yearly Net Income VS EBIT VS OCF VS FCFWBEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 0 -5M -10M -15M -20M

1.2 Ratios

WBEV has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WBEV Yearly ROA, ROE, ROICWBEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 0 500 -500 1K

1.3 Margins

WBEV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WBEV Yearly Profit, Operating, Gross MarginsWBEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

WBEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
WBEV has about the same amout of shares outstanding than it did 1 year ago.
WBEV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
WBEV Yearly Shares OutstandingWBEV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M
WBEV Yearly Total Debt VS Total AssetsWBEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -2.14, we must say that WBEV is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.14, WBEV is doing worse than 72.22% of the companies in the same industry.
WBEV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.14
ROIC/WACCN/A
WACC13.52%
WBEV Yearly LT Debt VS Equity VS FCFWBEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 0 10M -10M 20M -20M

2.3 Liquidity

WBEV has a Current Ratio of 1.06. This is a normal value and indicates that WBEV is financially healthy and should not expect problems in meeting its short term obligations.
WBEV's Current ratio of 1.06 is on the low side compared to the rest of the industry. WBEV is outperformed by 75.00% of its industry peers.
WBEV has a Quick Ratio of 1.06. This is a bad value and indicates that WBEV is not financially healthy enough and could expect problems in meeting its short term obligations.
WBEV has a Quick ratio of 0.27. This is amonst the worse of the industry: WBEV underperforms 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.27
WBEV Yearly Current Assets VS Current LiabilitesWBEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for WBEV have decreased strongly by -109.40% in the last year.
The Revenue has grown by 11.38% in the past year. This is quite good.
The Revenue has been growing by 21.05% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-109.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.06%
Revenue 1Y (TTM)11.38%
Revenue growth 3Y21.05%
Revenue growth 5YN/A
Sales Q2Q%-14.36%

3.2 Future

WBEV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.91% yearly.
Based on estimates for the next years, WBEV will show a quite strong growth in Revenue. The Revenue will grow by 8.43% on average per year.
EPS Next Y70.62%
EPS Next 2Y34.66%
EPS Next 3Y19.79%
EPS Next 5Y11.91%
Revenue Next Year-3.84%
Revenue Next 2Y-0.43%
Revenue Next 3Y10.52%
Revenue Next 5Y8.43%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
WBEV Yearly Revenue VS EstimatesWBEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
WBEV Yearly EPS VS EstimatesWBEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1 -2 -3 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

WBEV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year WBEV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WBEV Price Earnings VS Forward Price EarningsWBEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WBEV Per share dataWBEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

WBEV's earnings are expected to grow with 19.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.66%
EPS Next 3Y19.79%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WBEV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WINC INC

NYSEARCA:WBEV (12/12/2022, 8:22:15 PM)

After market: 0.14 0 (0%)

0.14

-0.03 (-20%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-14 2022-11-14/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners21.55%
Ins Owner Change0%
Market Cap1.84M
Analysts80
Price Target3.83 (2635.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-44.83%
Min EPS beat(2)-47.06%
Max EPS beat(2)-42.6%
EPS beat(4)2
Avg EPS beat(4)-17.12%
Min EPS beat(4)-47.06%
Max EPS beat(4)20.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.96%
Min Revenue beat(2)-18.69%
Max Revenue beat(2)-13.23%
Revenue beat(4)1
Avg Revenue beat(4)-7.41%
Min Revenue beat(4)-18.69%
Max Revenue beat(4)6.5%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.67%
PT rev (3m)N/A
EPS NQ rev (1m)-33.33%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-17.54%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-14.43%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-8.06%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.14
P/tB 0.71
EV/EBITDA N/A
EPS(TTM)-1.7
EYN/A
EPS(NY)-0.84
Fwd EYN/A
FCF(TTM)-1.21
FCFYN/A
OCF(TTM)-1.16
OCFYN/A
SpS5.36
BVpS1.03
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 75.05%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.27
Altman-Z -2.14
F-Score2
WACC13.52%
ROIC/WACCN/A
Cap/Depr(3y)77.39%
Cap/Depr(5y)84.9%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-109.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.06%
EPS Next Y70.62%
EPS Next 2Y34.66%
EPS Next 3Y19.79%
EPS Next 5Y11.91%
Revenue 1Y (TTM)11.38%
Revenue growth 3Y21.05%
Revenue growth 5YN/A
Sales Q2Q%-14.36%
Revenue Next Year-3.84%
Revenue Next 2Y-0.43%
Revenue Next 3Y10.52%
Revenue Next 5Y8.43%
EBIT growth 1Y-161.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year9.95%
EBIT Next 3Y21.06%
EBIT Next 5Y15.01%
FCF growth 1Y-36653.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5162.29%
OCF growth 3YN/A
OCF growth 5YN/A